References:
1. Waldner M, Schimanski CC, Neurath MF. Colon cancer and the immune system: the role of tumor invading T cells. World J Gastroenterol. 2006;12(45):7233-8.
2. Organization WH. World health statistics 2020: monitoring health for the SDGs sustainable development goals. 2020.
3. Organization. WH. Global action plan for the prevention and control of NCDs. 2016.
4. Jacqueline C, Tasiemski A, Sorci G, Ujvari B, Maachi F, Missé D, et al. Infections and cancer: the “fifty shades of immunity” hypothesis. BMC Cancer. 2017;17(1):257.
5. Emanuele Liardo RL, Borzì AM, Spatola C, Martino B, Privitera G, Basile F, et al. Effects of infections on the pathogenesis of cancer. Indian J Med Res. 2021;153(4):431-45.
6. Kaufman HL, Kohlhapp FJ, Zloza A. Oncolytic viruses: a new class of immunotherapy drugs. Nat Rev Drug Discov. 2016;15(9):660.
7. Ali MI, Abd El Wahab WM, Hamdy DA, Hassan A. Toxoplasma gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level. J Parasit Dis. 2019;43(3):464-71.
8. Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus and Clonorchis sinensis). IARC Monogr Eval Carcinog Risks Hum. 1994;61:121-75.
9. Herrera LA, Ostrosky-Wegman P. Do helminths play a role in carcinogenesis? Trends Parasitol. 2001;17(4):172-5.
10. Zaghloul MS. Bladder cancer and schistosomiasis. J Egypt Natl Canc Inst. 2012;24(4):151-9.
11. Sripa B, Brindley PJ, Mulvenna J, Laha T, Smout MJ, Mairiang E, et al. The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer. Trends Parasitol. 2012;28(10):395-407.
12. Botelho MC, Alves H, Richter J. Wound healing and cancer progression in Opisthorchis viverrini associated cholangiocarcinoma. Parasitol Res. 2016;115(7):2913-4.
13. Chai JY, Jung BK, Hong SJ. Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update. Korean J Parasitol. 2021;59(3):189-225.
14. Ujvari B, Beckmann C, Biro PA, Arnal A, Tasiemski A, Massol F, et al. Cancer and life-history traits: lessons from host-parasite interactions. Parasitology. 2016;143(5):533-41.
15. Sithithaworn P, Andrews RH, Nguyen VD, Wongsaroj T, Sinuon M, Odermatt P, et al. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int. 2012;61(1):10-6.
16. Petney TN, Andrews RH, Saijuntha W, Wenz-Mücke A, Sithithaworn P. The zoonotic, fish-borne liver flukes Clonorchis sinensis, Opisthorchis felineus and Opisthorchis viverrini. Int J Parasitol. 2013;43(12-13):1031-46.
17. Sripa B, Bethony JM, Sithithaworn P, Kaewkes S, Mairiang E, Loukas A, et al. Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop. 2011;120 Suppl 1(Suppl 1):S158-68.
18. Botelho MC, Vale N, Gouveia MJ, Rinaldi G, Santos J, Santos LL, et al. Tumour-like phenotypes in urothelial cells after exposure to antigens from eggs of Schistosoma haematobium: an oestrogen-DNA adducts mediated pathway? Int J Parasitol. 2013;43(1):17-26.
19. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD, et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003;86(2-3):125-39.
20. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030-44.
21. Hodder SL, Mahmoud AA, Sorenson K, Weinert DM, Stein RL, Ouma JH, et al. Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection. Am J Trop Med Hyg. 2000;63(3-4):133-8.
22. Shiff C, Veltri R, Naples J, Quartey J, Otchere J, Anyan W, et al. Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana. Trans R Soc Trop Med Hyg. 2006;100(9):847-54.
23. Zheng YL, Amr S, Saleh DA, Dash C, Ezzat S, Mikhail NN, et al. Urinary bladder cancer risk factors in Egypt: a multicenter case-control study. Cancer Epidemiol Biomarkers Prev. 2012;21(3):537-46.
24. Salem S, Mitchell RE, El-Alim El-Dorey A, Smith JA, Barocas DA. Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt. BJU Int. 2011;107(2):206-11.
25. Shirzad H, Khorami S, Soozangar N, Yousefi M, Darani HY. Toxoplasma gondii but not Leishmania major or Trichomonas vaginalis decreases cell proliferation and increases cell death on fibrosarcoma cancer cells in culture medium. 2012.
26. Hamid HK. Schistosoma japonicum–associated colorectal cancer: a review. The American journal of tropical medicine and hygiene. 2019;100(3):501.
27. Salim OE, Hamid HK, Mekki SO, Suleiman SH, Ibrahim SZ. Colorectal carcinoma associated with schistosomiasis: a possible causal relationship. World journal of surgical oncology. 2010;8(1):1-6.
28. Bernardo C, Cunha MC, Santos JH, da Costa JMC, Brindley PJ, Lopes C, et al. Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics. Tumor Biology. 2016;37(8):11279-87.
29. Maeng S, Lee HW, Bashir Q, Im Kim T, Hong S-J, Lee TJ, et al. Oxidative stress-mediated mouse liver lesions caused by Clonorchis sinensis infection. International Journal for Parasitology. 2016;46(3):195-204.
30. von Bülow V, Lichtenberger J, Grevelding CG, Falcone FH, Roeb E, Roderfeld M. Does Schistosoma mansoni Facilitate Carcinogenesis? Cells. 2021;10(8):1982.
31. Sava M, Huynh T, Frugoli A, Kong L, Salehpour M, Barrows B. Colorectal cancer related to chronic Strongyloides stercoralis infection. Case Reports in Gastrointestinal Medicine. 2020;2020.
32. Lun Z-R, Lai D-H, Wen Y-Z, Zheng L-L, Shen J-L, Yang T-B, et al. Cancer in the parasitic protozoans Trypanosoma brucei and Toxoplasma gondii. Proceedings of the National Academy of Sciences. 2015;112(29):8835-42.
33. Vittecoq M, Elguero E, Lafferty KD, Roche B, Brodeur J, Gauthier-Clerc M, et al. Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France. Infection, Genetics and Evolution. 2012;12(2):496-8.
34. Thirugnanam S, Rout N, Gnanasekar M. Possible role of Toxoplasma gondii in brain cancer through modulation of host microRNAs. Infectious agents and cancer. 2013;8(1):1-6.
35. Thomas F, Lafferty KD, Brodeur J, Elguero E, Gauthier-Clerc M, Missé D. Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biol Lett. 2012;8(1):101-3.
36. Dirkx M, Boyer MP, Pradhan P, Brittingham A, Wilson WA. Expression and characterization of a β-fructofuranosidase from the parasitic protist Trichomonas vaginalis. BMC Biochem. 2014;15:12.
37. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40(3):187-93.
38. Sutcliffe S, Neace C, Magnuson NS, Reeves R, Alderete JF. Trichomonosis, a common curable STI, and prostate carcinogenesis--a proposed molecular mechanism. PLoS Pathog. 2012;8(8):e1002801.
39. Shui IM, Kolb S, Hanson C, Sutcliffe S, Rider JR, Stanford JL. Trichomonas vaginalis infection and risk of advanced prostate cancer. Prostate. 2016;76(7):620-3.
40. Fowke JH, Han X, Alderete JF, Moses KA, Signorello LB, Blot WJ. A prospective study of Trichomonas vaginalis and prostate cancer risk among African American men. BMC Res Notes. 2016;9:224.
41. Steer H. Blastocystis hominis and colorectal cancer. Ann R Coll Surg Engl. 2007;89(5):539.
42. Kumarasamy V, Kuppusamy UR, Jayalakshmi P, Samudi C, Ragavan ND, Kumar S. Exacerbation of colon carcinogenesis by Blastocystis sp. PLoS One. 2017;12(8):e0183097.
43. Abdullah UH, Baig MZ, Azeemuddin M, Wasay M, Yakoob J, Beg MA. Amoebic brain abscess associated with renal cell carcinoma. Neurology and Clinical Neuroscience. 2017;5(6):195-7.
44. Leroy A, Mareel M, De Bruyne G, Bailey G, Nelis H. Metastasis of Entamoeba histolytica compared to colon cancer: one more step in invasion. Invasion & metastasis. 1994;14(1-6):177-91.
45. Morsy TA. Cutaneous leishmaniasis predisposing to human skin cancer: forty years local and regional studies. Journal of the Egyptian Society of Parasitology. 2013;43(3):629-48.
46. Kopterides P, Mourtzoukou EG, Skopelitis E, Tsavaris N, Falagas ME. Aspects of the association between leishmaniasis and malignant disorders. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2007;101(12):1181-9.
47. Hirata T, Kishimoto K, Kinjo N, Hokama A, Kinjo F, Fujita J. Association between Strongyloides stercoralis infection and biliary tract cancer. Parasitol Res. 2007;101(5):1345-8.
48. Kalantari N, Gorgani-Firouzjaee T, Ghaffari S, Bayani M, Ghaffari T, Chehrazi M. Association between Cryptosporidium infection and cancer: A systematic review and meta-analysis. Parasitol Int. 2020;74:101979.
49. Fried B, Reddy A, Mayer D. Helminths in human carcinogenesis. Cancer Lett. 2011;305(2):239-49.
50. Darani HY, Shirzad H, Mansoori F, Zabardast N, Mahmoodzadeh M. Effects of Toxoplasma gondii and Toxocara canis antigens on WEHI-164 fibrosarcoma growth in a mouse model. Korean J Parasitol. 2009;47(2):175-7.
51. Badri M, Kiani Z, Faridnia R, Mousavi M, Mehrabi H, Pestechian N, et al. Effect of Toxocara canis and Toxascaris leonina egg antigens on induction of eosinophilia in animal model. Journal of Shahrekord Uuniversity of Medical Sciences. 2014;16.
52. Berriel E, Russo S, Monin L, Festari MF, Berois N, Fernández G, et al. Antitumor activity of human hydatid cyst fluid in a murine model of colon cancer. The Scientific World Journal. 2013;2013.
53. Tabatabaie F, Samarghandi N, Zarrati S, Maleki F, Ardestani M, Elmi T, et al. Induction of Immune Responses by DNA Vaccines Formulated with Dendrimer and Poly (Methyl Methacrylate)(PMMA) Nano-Adjuvants in BALB/c Mice Infected with Leishmania major. Open Access Maced J Med Sci. 2018 Feb 15; 6 (2): 229-236. 2018.
54. Medeiros A, Chiribao ML, Ubillos L, Festari MF, Saldana J, Robello C, et al. Mucin-type O-glycosylation in Mesocestoides vogae (syn. corti). International journal for parasitology. 2008;38(3-4):265-76.
55. Oliveira E, Leite M, Miranda J, Andrade A, Garcia S, Luquetti A, et al. Chronic Trypanosoma cruzi infection associated with low incidence of 1, 2-dimethylhydrazine-induced colon cancer in rats. Carcinogenesis. 2001;22(5):737-40.
56. Zhu Z, Davidson KT, Brittingham A, Wakefield MR, Bai Q, Xiao H, et al. Trichomonas vaginalis: a possible foe to prostate cancer. Medical Oncology. 2016;33(10):1-8.
57. Salanti A, Clausen TM, Agerbæk MØ, Al Nakouzi N, Dahlbäck M, Oo HZ, et al. Targeting human cancer by a glycosaminoglycan binding malaria protein. Cancer cell. 2015;28(4):500-14.
58. Lopes MF, Zamboni DS, Lujan HD, Rodrigues MM. Immunity to protozoan parasites. Hindawi; 2012.
59. Hajialiani F, Elmi T, Mohamadi M, Sadeghi S, Shahbazzadeh D, Ghaffarifar F, et al. Analysis of the active fraction of Iranian Naja naja oxiana snake venom on the metabolite profiles of the malaria parasite by (1)HNMR in vitro. Iran J Basic Med Sci. 2020;23(4):534-43.
60. Elmi T, Amni F, Esboei BR, Gholami S, Akbariqomi M, Mortazavi M, et al. Evaluation of Blastocystis sp. Frequency in Referred Samples to Urban Laboratories: Is it a Potential Risk for Deployed Troops? Journal of Archives in Military Medicine. 2019;7(1-2).
61. Elmi T, Rahimi Esboei B, Sadeghi F, Zamani Z, Didehdar M, Fakhar M, et al. In Vitro Antiprotozoal Effects of Nano-chitosan on Plasmodium falciparum, Giardia lamblia and Trichomonas vaginalis. Acta Parasitol. 2021;66(1):39-52.
62. Gurung P, Kanneganti TD. Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors. Cell Mol Life Sci. 2016;73(16):3035-51.
63. Berriel E, Russo S, Monin L, Festari MF, Berois N, Fernández G, et al. Antitumor activity of human hydatid cyst fluid in a murine model of colon cancer. Scientific World Journal. 2013;2013:230176.
64. Khan IA, Thomas SY, Moretto MM, Lee FS, Islam SA, Combe C, et al. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog. 2006;2(6):e49.
65. Chaudhry SA, Gad N, Koren G. Toxoplasmosis and pregnancy. Can Fam Physician. 2014;60(4):334-6.
66. Amari A, Razavi A, Jamali A, AminiSardrod A, Motamedi M, Shojaee S, et al. Effects of dendritic cell vaccine activated with protein components of Toxoplasma gondii on tumor specific CD8+ T-cells. Tehran University Medical Journal. 2009;67(9).
67. Motamedi M, Arab S, Moazzeni SM, Khamis Abadi M, Hadjati J. Improvement of a dendritic cell-based therapeutic cancer vaccine with components of Toxoplasma gondii. Clinical and Vaccine Immunology. 2009;16(10):1393-8.
68. Aline F, Bout D, Amigorena S, Roingeard P, Dimier-Poisson I. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infect Immun. 2004;72(7):4127-37.
69. Kang HK, Lee HY, Lee YN, Jo EJ, Kim JI, Aosai F, et al. Toxoplasma gondii-derived heat shock protein 70 stimulates the maturation of human monocyte-derived dendritic cells. Biochem Biophys Res Commun. 2004;322(3):899-904.
70. Aosai F, Rodriguez Pena MS, Mun HS, Fang H, Mitsunaga T, Norose K, et al. Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4. Cell Stress Chaperones. 2006;11(1):13-22.
71. Khurana S, Dubey ML, Malla N. Association of parasitic infections and cancers. Indian J Med Microbiol. 2005;23(2):74-9.
72. Daneshpour S, Baradaran M, Yousefi M, Mortazavi-Dehkordi N, Mahmoudzadeh M, Eskandarian A, et al. Immunological cross reaction between cancer cells and hydatid cyst. Journal of Shahrekord University of Medical Sciences. 2014;16(1).
73. Baldus SE, Engelmann K, Hanisch F-G. MUC1 and the MUCs: a family of human mucins with impact in cancer biology. Critical reviews in clinical laboratory sciences. 2004;41(2):189-231.
74. McSorley HJ, Hewitson JP, Maizels RM. Immunomodulation by helminth parasites: defining mechanisms and mediators. International Journal for Parasitology. 2013;43(3-4):301-10.
75. Anthony RM, Rutitzky LI, Urban JF, Stadecker MJ, Gause WC. Protective immune mechanisms in helminth infection. Nature Reviews Immunology. 2007;7(12):975-87.
76. Moris P, Jongert E, van der Most RG. Characterization of T-cell immune responses in clinical trials of the candidate RTS, S malaria vaccine. Human vaccines & immunotherapeutics. 2018;14(1):17-27.
77. Nacher M. Malaria vaccine trials in a wormy world. Trends in Parasitology. 2001;17(12):563-5.
78. Bouchery T, Kyle R, Ronchese F, Le Gros G. The differentiation of CD4+ T-helper cell subsets in the context of helminth parasite infection. Frontiers in Immunology. 2014;5:487.
79. Elliott AM, Mawa PA, Joseph S, Namujju PB, Kizza M, Nakiyingi JS, et al. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults. Trans R Soc Trop Med Hyg. 2003;97(1):103-8.
80. Thomas PG, Harn DA, Jr. Immune biasing by helminth glycans. Cell Microbiol. 2004;6(1):13-22.
81. Çelik F, Şimşek S. Parasite and Cancer Relationship. Turkiye Parazitol Derg. 2022;46(2):150-62.
82. Herman AM, Kishe A, Babu H, Shilanaiman H, Tarmohamed M, Lodhia J, et al. Colorectal cancer in a patient with intestinal schistosomiasis: a case report from Kilimanjaro Christian Medical Center Northern Zone Tanzania. World J Surg Oncol. 2017;15(1):146.
83. Baldus SE, Engelmann K, Hanisch FG. MUC1 and the MUCs: a family of human mucins with impact in cancer biology. Crit Rev Clin Lab Sci. 2004;41(2):189-231.
84. Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol. 1996;25(5):933-40.
85. Choi BI, Han JK, Hong ST, Lee KH. Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis. Clin Microbiol Rev. 2004;17(3):540-52, table of contents.
86. Fox BA, Butler KL, Guevara RB, Bzik DJ. Cancer therapy in a microbial bottle: Uncorking the novel biology of the protozoan Toxoplasma gondii. PLOS Pathogens. 2017;13(9):e1006523.
87. Sutcliffe S, Alderete JF, Till C, Goodman PJ, Hsing AW, Zenilman JM, et al. Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial. Int J Cancer. 2009;124(9):2082-7.
88. Sulżyc-Bielicka V, Kołodziejczyk L, Jaczewska S, Bielicki D, Safranow K, Bielicki P, et al. Colorectal cancer and Cryptosporidium spp. infection. PLOS ONE. 2018;13(4):e0195834.
89. León-Cabrera S, Callejas BE, Ledesma-Soto Y, Coronel J, Pérez-Plasencia C, Gutiérrez-Cirlos EB, et al. Extraintestinal helminth infection reduces the development of colitis-associated tumorigenesis. Int J Biol Sci. 2014;10(9):948-56.
90. Freire T, Casaravilla C, Carmona C, Osinaga E. Mucin-type O-glycosylation in Fasciola hepatica: characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity. Int J Parasitol. 2003;33(1):47-56.
91. Ubillos L, Freire T, Berriel E, Chiribao ML, Chiale C, Festari MF, et al. Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers. Int J Cancer. 2016;138(7):1719-31.
)